Cigarette smoke components modulate the MR1-MAIT axis.

Area of Science:

• Immunology
• Respiratory Medicine
• Toxicology

Background:

• Tobacco smoking is a global health issue linked to various diseases.
• Cigarette smoke (CS) is known to compromise the immune system, but its specific effects on T cell function are not fully understood.
• Mucosal-associated invariant T (MAIT) cells, abundant in the lungs, are critical for immune responses and interact with the MR1 molecule.

Purpose of the Study:

• To identify components in cigarette smoke that interact with the MR1 molecule.
• To investigate the impact of CS on MAIT cell function and phenotype.
• To explore the role of MR1 in CS-induced lung disease, such as COPD.

Main Methods:

• In silico, cellular, and biochemical analyses were employed to study CS components and MR1 interactions.
• MAIT cell activation and function were assessed ex vivo and in vivo following CS exposure.
• MR1-deficient mice were used to evaluate the role of MR1 in CS-induced COPD features.

Main Results:

• Specific CS compounds, including nicotinaldehyde and benzaldehyde derivatives, were found to bind to the MR1 molecule.
• CS inhibited MAIT cell activation through both TCR-dependent and independent pathways.
• Chronic CS exposure altered MAIT cell phenotype, reduced their function, and impaired responses to influenza A virus infection.
• MR1-deficient mice showed partial protection against CS-induced COPD development.

Conclusions:

• Cigarette smoke contains compounds that directly interact with MR1, leading to impaired MAIT cell function.
• CS affects MAIT cells via multiple mechanisms, potentially increasing susceptibility to infections and exacerbating respiratory diseases like COPD.
• Targeting MR1-mediated pathways could be a strategy for mitigating CS-induced immune dysfunction and disease progression.